































































Inflammatory	 airway	 disease	 (IAD)	 describes	 a	 condition	 of	 non-septic	
inflammation	of	 the	 lower	 airways	 in	horses.	The	disease	occurs	principally	 in	
adult	 horses	 and	 has	 an	 apparent	 worldwide	 distribution.	 The	 most	 common	
clinical	signs	of	IAD	include	poor	athletic	performance,	cough,	and/or	increased	
tracheobronchial	 secretions.	 	 Inconsistencies	 in	 disease	 definition,	 sampling	
methods	and	laboratory	techniques	have	limited	comparisons	between	studies.	
	
Essential	 criteria	 for	diagnosis	of	 IAD,	 as	 stated	by	 the	2007	ACVIM	consensus	
statement,	 include	 documentation	 of	 non-septic	 inflammation	 or	 pulmonary	
dysfunction	 based	 on	 evidence	 of	 lower	 airway	 obstruction,	 airway	 hyper-
responsiveness,	 or	 impaired	 blood	 gas	 exchange	 at	 rest	 or	 during	 exercise.	 A	
definitive	 diagnosis	 is	 currently	 based	 on	 bronchoalveolar	 lavage	 fluid	 (BALF)	
cytology	and/or	pulmonary	function	testing	(PFT).	
	
The	 correlation	 between	 BALF	 cytology	 and	 pulmonary	 function	 testing	 (PFT)	
has	been	poorly	defined.	The	primary	aim	of	this	study	was	to	characterise	the	






On	 the	 basis	 of	 BALF	 cytology	 the	 majority	 of	 horses	 in	 this	 study	 had	 lower	
airway	inflammation	as	defined	by	published	criteria.	The	study	thus	highlights	
that	normal	values	for	cell	proportions	in	BALF	might	vary	between	populations	
of	 horses.	 Despite	 an	 obvious	 overlap	 between	 inflammatory	 BALF	 cytological	




Acceptable	 reliability	 {ICC:	 0.655	 (95%	 CI:	 0.098,	 0.952;	 significance:	 0.011)})	
was	 demonstrated	 using	 the	 Flowmetrics	 Plethysmography™	 system	 with	
histamine	bronchoprovocation.		
	
In	 conclusion,	 airway	 inflammation	 and	 airway	 hyperreactivity	 are	 loosely	
related	to	each	other	in	this	population	of	horses.		The	presence	of	inflammatory	
cells	 does	 not	 necessarily	 predict	 airway	 hyperresponsiveness	 on	 the	 basis	 of	
histamine	bronchoprovocation.	Likewise,	airway	hyperresponsiveness	can	occur	
in	 the	 absence	 of	 a	 BALF	 inflammatory	 profile.	 	 Further	 investigation	 of	 other	
potential	factors	such	as	inherited	abnormalities	of	smooth	muscle	contractility,	
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Figure	8:		 The	horse	 is	 sedated	and	 restrained	 in	 stocks	with	a	nose	 twitch	
applied.	 The	 BAL	 tube	 is	 advanced	 up	 the	 nostril	 and	 into	 the	
trachea.	(page	50)	
	
Figure	9:		 Bronchoalveolar	 lavage	 tube	 is	 gently	 pressed	 against	 the	 nasal	
septum	with	 the	 thumb	to	secure	 its	position	at	 the	nostril	while	
saline	is	infused	using	60	mL	syringes.	(page	51)	
	
Figure	10:		 After	 each	 aliquot	 of	 saline	 is	 infused	 it	 is	 then	 gently	 aspirated	
using	60	mL	syringes.	(page	51)	
	






























Table	7:		 Subjective	 data	 for	 part	 1	 of	 study	 showing	 histamine	
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Inflammatory	 airway	 disease	 (IAD)	 describes	 a	 condition	 of	 non-septic	
inflammation	of	 the	 lower	airways	 in	horses.	Essential	 criteria	 for	diagnosis	of	
IAD	as	stated	by	the	2007	ACVIM	consensus	statement	include	documentation	of	
either	non-septic	 inflammation	or	pulmonary	dysfunction	based	on	evidence	of	



















as	 demonstrated	 by	 bronchoalveolar	 lavage	 cytology,	 and	 airway	
hyperresponsiveness.		
	
2. Flowmetric	 plethysmography	 with	 histamine	 bronchoprovocation	 using	





















unique	 phenotype	 of	 chronic	 airway	 disease,	 and	 was	 distinct	 from	 the	 well-
defined	 chronic	 lung	 disease	 now	 known	 as	 RAO.	 The	 latter	 term	 was	
recommended	for	the	mature	horse	with	airway	obstruction	that	is	reversed	by	a	
change	 in	 environment	 or	 the	 use	 of	 bronchodilators.	 A	 separate	 syndrome	 of	
non-septic	 lower	 airway	 disease,	 that	 appeared	 to	 be	 particularly	 common	 in	




septic	 inflammation	 of	 the	 lower	 airway.	 Past	 studies	 have	 described	 what	 is	
now	termed	IAD	as	‘chronic	bronchiolitis’	(3-5),	‘mild	bronchiolitis’	(6)	and	small	




of	 non-septic	 inflammation,	 as	 defined	 through	 bronchoalveolar	 lavage	 fluid	
(BALF)	 cytology	 or	 pulmonary	dysfunction	based	 on	 evidence	 of	 lower	 airway	





Inflammatory	 airway	disease	 is	 a	 disease	 of	 adult	 horses	 that	 has	 an	 apparent	
worldwide	distribution.	A	very	wide	range	(1.8%	to	80%)	in	disease	prevalence	
has	 been	 reported	 (4,8-11).	 Comparison	 between	 studies	 has	 been	 extremely	






American	 study	 undertaken	 in	 1991,	 where	 horses	 were	 presented	 for	
evaluation	 of	 poor	 performance	 (4).	 Although	 22%	 of	 these	 cases	 were	
diagnosed	with	respiratory	problems,	only	1.8%	of	horses	were	diagnosed	with	




Much	 of	 our	 understanding	 of	 IAD	 is	 derived	 from	 studies	 that	 have	 used	






study	 reported	 an	 average	 annual	 prevalence	 of	 80%	 in	 2-year–old	
Thoroughbred	 racehorses	 (8).	 In	 poorly	 performing	 horses	 with	 cytological	
evidence	of	IAD	in	bronchoalveolar	lavage	and/or	TW	fluid	a	prevalence	of	65%	
has	 been	 reported	 (9).	 Unfortunately	 the	 disease	 definition	 criteria	 using	




Likewise	 in	 a	 UK	 study	 to	 quantify	 the	 causes	 of	 pulmonary	 disease	 in	 adult	
horses	presenting	 to	 referral	practices	 in	 the	United	Kingdom	(1)	 cases	of	 IAD	
were	likely	under-represented	through	poor	case	definitions.	Horses	in	the	study	
were	categorised	 into	8	groups	dependent	on	a	combination	of	history,	clinical	
signs	 and	 diagnostic	 testing.	 Horses	 with	 IAD	 as	 per	 today’s	 definition	 by	 the	






TW	 mucus	 and	 neutrophilic	 inflammation)	 and	 age,	 with	 some	 studies	
demonstrating	 that	 prevalence	 decreases	 with	 age	 (8,11-13)	 and	 others	
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reporting	the	opposite	(10,14).	Robinson	et	al.	(2006)	reported	that	older	horses	
were	 at	 risk	 for	 airway	 neutrophilia	 (>20%	 neutrophils),	 but	 the	 increase	 in	
percentage	neutrophils	with	age	was	a	consequence	to	a	relative	decrease	in	the	
number	 of	 macrophages	 rather	 than	 an	 increase	 in	 neutrophils	 (10).	 As	 with	
earlier	 studies	 IAD	 was	 diagnosed	 in	 the	 aforementioned	 studies	 using	 TW	










Two	 potential	 hypotheses	 exist	 for	 impairment	 in	 gas	 exchange.	 The	 first	




gas	 partial	 pressure	 between	 the	 two	 sides,	 and	 inversely	 proportional	 to	 the	
tissue	thickness	(20).	In	horses	with	IAD,	the	inflammatory	response	in	the	lower	
airway	 may	 lead	 to	 thickening	 of	 the	 blood	 gas	 barrier	 and	 therefore	 limit	
diffusion	 of	 oxygen	 between	 the	 alveolar	 space	 and	 the	 pulmonary	 capillary	
blood	 thus	 impairing	 lung	 function.	 This	 opinion	 however	 is	 not	 universally	
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accepted.	Nyman	et	al.	(1999)	reported	that	Standardbred	racehorses	with	IAD,	
diagnosed	 on	 the	 basis	 of	 lung	 biopsy,	 could	 achieve	 adequate	 gas	 exchange	




















Several	 epidemiological	 studies	 undertaken	 in	 the	 UK	 and	 Australia	 have	
indicated	 that	 bacterial	 infection	 plays	 a	 major	 role	 in	 lower	 respiratory	 tract	
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disease	 in	 racehorses	 (11,12,22-24,26,33,34).	 The	 bacteria	 most	 commonly	




IAD	 and	 recovery	 of	 Streptococcus	 equi	 subspecies	 zooepidemicus	 and	
Streptococcus	pneumoniae	from	tracheal	cultures	(11,22).	The	authors	concluded	
that	 this	 finding	 was	 due	 to	 increased	 disease	 resistance	 associated	 with	 the	
development	 of	 immunity	 to	 infectious	 agents	 (11,22).	 Other	 authors	 have	
suggested	 that	 resolution	 of	 bacterial	 infection	 may	 result	 in	 residual	
inflammation	 of	 the	 lower	 airways	 with	 resultant	 cough	 (24).	 A	 number	 of	
studies	 have	 suggested	 that	 horses	 with	 cytological	 evidence	 of	 lower	 airway	






there	are	 few	studies	 that	have	 investigated	the	potential	role	of	viruses	 in	 the	
pathogenesis	of	 IAD.	There	 is	 some	evidence	 that	equine	herpes	viruses	 (EHV)	
type	1	 and	 type	 4	may	be	 associated	with	 IAD	 (22,35),	 but	 other	 studies	 have	
failed	to	find	any	significant	association	between	viral	agents	and	equine	lower	





Bronchoalveolar	 lavage	 fluid	 (BALF)	 of	 horses	 with	 respiratory	 viral	 infection	
has	 been	 shown	 to	 contain	 a	 large	 amount	 of	 mucosal	 epithelial	 cells	 with	
numerous	 free	 cilia	 and	 detached	 ciliated	 tufts	 (36).	 Similar	 epithelial	 cell	





Conflicting	 reports	 demonstrating	 the	 association	 between	 IAD	 and	 upper	
respiratory	 tract	 (URT)	 abnormalities	 have	 been	 published,	 with	 some	 studies	
demonstrating	no	significant	association	(10,14,18,37)	while	others	demonstrate	
a	strong	association	(16,21).		Courouce-Malblanc	et	al.	(2002)	found	that	horses	
with	 upper	 respiratory	 tract	 disease,	 such	 as	 dorsal	 displacement	 of	 the	 soft	
palate	 (DDSP),	 showed	 a	 significantly	 higher	 BALF	 neutrophil	 percentage	







Histopathological	 studies	 have	 shown	 the	 presence	 of	 bronchiolitis	 in	 areas	 of	
lung	affected	by	EIPH	(38).	Early	studies	reported	an	association	between	EIPH	




by	 Chapman	 and	 others	 (12).	 This	 was	 further	 supported	 by	 Allen	 and	 co-
workers	(2006)	who	reported	no	significant	association	between	EIPH	and	the	
presence	of	 tracheal	mucus	or	 increased	neutrophils	 in	TW	or	BAL	cytology	 in	





Repeated	 administration	 of	 blood	 into	 the	 airways	 can	 cause	 alterations	 that	
result	in	an	impairment	of	respiratory	mechanics	as	demonstrated	by	a	decrease	
in	 dynamic	 compliance	 and	 increase	 in	 pulmonary	 resistance	 (43).	 Aguilera-
Tejero	and	co-workers	(1995)	suggested	that	 these	changes	were	attributed	to	
the	 subsequent	 airway	 inflammation	 induced	 by	 the	 presence	 of	 blood.	 In	







horses,	 including	 non-septic	 conditions	 such	 as	 IAD.	 At	 rest,	 inspired	 air	 is	
warmed	to	body	temperature	and	fully	humidified	by	the	upper	airway	mucosa.	
When	 the	 inspired	 air	 is	 cold	 or	 during	 increased	 minute	 ventilation,	
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conditioning	 by	 the	 upper	 airway	 may	 be	 insufficient,	 resulting	 in	 cooling	 and	
desiccation	of	lower	airway	mucosa.	The	resultant	heat	and	water	loss	from	the	
lower	 airways	 is	 believed	 to	 be	 the	 provocative	 stimulus	 for	 exercise-induced	
bronchoconstriction	in	humans	with	pre-existing	airway	hyper-reactivity.		
	
A	 study	 by	Davis	 et	 al.	 (2005)	 found	 significant	 increases	 in	 pro-inflammatory	
cytokines	 (Interleukin	 (IL)	 -2,	 IL-4,	 IL-5	 and	 IL-6)	 in	 the	 airways	of	 a	 group	of	
normal	horses	5	hours	after	exercising	while	breathing	cold	air	 (46).	 In	a	 later	
study	by	the	same	group,	increases	in	pro-inflammatory	cytokines	IL-1,	IL-6	and	
IL-8	 were	 reported	 24h	 after	 exercising	 while	 breathing	 cold	 air	 in	 normal	
horses	 (47).	 Davis	 and	 co-workers	 also	 demonstrated	 that	 the	 proportion	 of	
neutrophils	in	BALF	was	significantly	higher	in	these	horses	when	compared	to	a	






found	 during	 the	 winter	 months	 in	 a	 survey	 of	 Thoroughbred	 racehorses	 in	













dust,	 such	 as	 that	 found	 in	 hay	 (27,32)	 and	 bedding	 (23)	 can	 induce	 airway	
inflammation.	 Horses	 that	 consume	 hay,	 especially	 from	 round	 bales,	
demonstrate	 increased	 number	 of	 neutrophils	 in	 lower	 airway	 secretions	 (10,	
27)	 and	 the	 overall	 dust	 content	 of	 hay	 and	 concentrations	 of	 dust	 in	 the	
breathing	 zone	 can	 exceed	 20	 mg/m3	 of	 air	 when	 horses	 eat	 from	 bales	 (31).	
Burrell	 et	 al.	 (1996)	 reported	 that	 horses	 bedded	 on	 paper	 were	 less	 likely	 to	
develop	lower	airway	disease	than	those	bedded	on	straw	in	loose	boxes	(23).	In	
a	group	of	horses	with	poor	performance	and	BALF	neutrophilia,	diagnosed	with	
IAD,	positive	 clinical	 responses	were	 found	when	environmental	 changes	were	
made	 such	 as	 alterations	 in	 bedding	 materials,	 feeding	 practices	 and	 stable	
ventilation	(50).			
	
In	 a	 US	 study,	 significant	 associations	 were	 found	 between	 the	 presence	 of	
visible	 accumulations	 of	 tracheal	 mucus	 and	 the	 concentration	 and	 size	 of	
particles	within	a	stable	 (51).	A	UK	study	 found	that	 the	mean	duration	of	 IAD	
incidents	was	significantly	higher	for	horses	kept	in	an	environment	where	dust	




barn	or	near	 areas	of	 high	 traffic,	 such	 as	doorways	or	 adjacent	 to	busy	 roads	
were	 shown	 to	 be	 at	 greatest	 risk	 of	 high	 particulate	 counts	 in	 a	 study	 by	
Millerick-May	 and	 co-workers.	 Insufficient	 ventilation	 within	 enclosed	 brick	
stables	 also	 increased	 the	 risk	 of	 exposure	 to	 particulate	 matter	 and	
development	 of	 excess	 tracheal	 mucus	 (51).	 The	 increased	 challenges	 to	 the	
respiratory	 tract	 from	microorganisms	or	allergens	may	affect	 the	clearance	of	
pathogens	 and	 change	 local	 or	 systemic	 immune	 resistance	 thus	 resulting	 in	
inflammation	(52).		
	
Endotoxin,	 a	 major	 pro-inflammatory	 glycolipid	 component	 of	 gram-negative	
bacteria,	 is	 a	 constituent	 of	 airborne	 dusts	 and	 has	 been	 shown	 to	 play	 an	
important	role	in	lower	airway	inflammation	in	horses	(32)	and	in	other	species	
(53,54).	 Inhalation	 of	 endotoxin	 results	 in	 a	 dose-dependent	 increase	 in	 the	
concentration	 of	 tumour	 necrosis	 factor	 (TNF)	 in	 BAL	 fluid	 in	 rats	 (53).	
Aerosolized	 TNF	 induces	 an	 influx	 of	 neutrophils	 in	 BALF	 and	 the	
lipopolysaccharide	(LPS)-induced	neutrophil	 influx	was	partly	inhibited	by	pre-
treatment	 with	 anti-TNF	 antibodies	 in	 their	 study	 (53).	 Schwartz	 et	 al.	 (1994)	
demonstrated	that	endotoxin	is	a	critical	component	in	the	development	of	grain	
dust-induced	 inflammation	 in	 the	 lower	 respiratory	 tract	 of	 humans	 (54).	
Collection	of	BALF	5h	 after	 the	 start	 of	 exposure	 to	 endotoxin	demonstrated	 a	





found	 between	 neutrophilic	 airway	 inflammation	 and	 exposure	 to	 high	
respirable	 endotoxin	 concentrations	 in	 an	 Australian	 study	 of	 young	
Thoroughbred	racehorses	(32).		
	
Although	stabling	of	racehorses	has	been	 implicated	as	a	risk	 factor	 for	clinical	
respiratory	disease	(32),	there	is	also	good	evidence	that	bringing	asymptomatic	
horses	 of	 varying	 age	 groups	 from	 pasture	 into	 a	 conventional	 stable	















Poor	 athletic	 performance	 is	 a	 significant	 problem	 in	 the	 horse	 industry.	
Although	poor	athletic	performance	 is	often	 subjective,	 and	 client	expectations	
frequently	 outweigh	 the	 horse’s	 athletic	 ability	 (1),	 horses	 can	 perform	poorly	
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for	 a	 multitude	 of	 reasons	 beyond	 limitations	 related	 to	 ability	 and	 fitness	
(4,9,37,57-59).	Many	problems	are	subtle	and	a	number	of	studies	have	reported	
multiple	 factors	 contribute	 to	 horses	 performing	 poorly,	 with	 respiratory	 and	
musculoskeletal	disease	being	overrepresented	(4,9,49,59,60).		
	
While	 overt	 respiratory	 tract	 disease	 is	 a	 well-recognized	 cause	 of	 reduced	
performance,	 the	 impact	 of	 subclinical	 disease	 appears	 to	 be	 understated	 and	
poorly	 understood.	 In	 a	 UK	 study,	 65	 horses	 without	 clinical	 evidence	 of	
pulmonary	 disease	 were	 referred	 for	 pulmonary	 examination	 because	 of	 poor	
racing	performance,	pulmonary	disorders,	 including	 IAD,	were	attributed	to	35	
(58.3%)	of	 these	cases	(1).	Comparison	between	studies	 is	again	made	difficult	
due	 to	 poor	 disease	 recognition,	 particularly	 due	 to	 the	 subjectivity	 of	 poor	
performance	and	subtleness	of	clinical	signs	of	disease.		
	
A	 number	 of	 investigators	 have	 made	 an	 association	 between	 airway	
inflammation	and	exercise	intolerance	or	poor	performance	(4,50,61).	IAD	was	a	
common	 finding	 in	 National	 Hunt	 horses	 referred	 for	 investigation	 of	 poor	




With	 the	 exception	 of	 eventing	 horses,	 sport	 horses	 typically	 do	 not	 reach	
maximal	 cardio-respiratory	 effort	 during	 competition	 and	 subclinical	 airway	
disease,	 although	 present,	 may	 not	 limit	 performance	 (55).	 The	 apparent	 high	
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Studies	 in	 racehorses	 have	 found	 that	 cough	 diminishes	 with	 increasing	 age,	
suggesting	 either	 a	 development	 of	 immunity	 or	 tolerance	 to	 the	 aetiological	
agents,	 or	 alternatively	 that	 some	 other	 component	 may	 be	 more	 prevalent	 in	
younger	horses	(63).	Conversely,	Bedenice	et	al.	(2008)	found	that	coughing	was	
significantly	more	prevalent	in	horses	over	7	years	of	age	and	its	presence	was	






Mucus	 is	 produced	 by	 specialised	 cells	 called	 goblet	 cells	 in	 the	 respiratory	
epithelium	 and	 is	 an	 important	 part	 of	 the	mucociliary	 escalator	 that	 removes	
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infectious	 agents	 and	 environmental	 particulates	 from	 the	 lower	 airways.	
Mucociliary	 clearance	 is	 normally	 a	 very	 efficient	 process	 whereby	 mucus	
elimination	 keeps	 pace	 with	 mucus	 production,	 such	 that	 the	 airways	 contain	
minimal	mucocellular	material	with	low	numbers	of	cells	(41).	The	mucociliary	
“ladder”	 is	 estimated	 to	 transport	 mucus	 proximally	 at	 a	 rate	 of	 2-8	 mL/h	 in	
clinically	healthy	horses	(65)	and	some	mucus	is	expected	on	visual	inspection	of	





lower	 airway	 diseases	 (62)	 and	 in	 clinically	 healthy	 animals	 (55),	 particularly	
after	 fast	 exercise	 (68).	 Mucus	 accumulation	 also	 has	 been	 shown	 to	 develop	
when	RAO-affected	horses	are	stabled	and	fed	hay	(69,70).		
	
A	 tracheal	 mucus	 scoring	 system,	 where	 the	 amount	 of	 mucus	 present	 was	
graded	between	0	and	5,	was	validated	in	2004	(65).	Studies	have	demonstrated	
an	association	between	moderate	to	severe	accumulations	of	tracheal	mucus	and	
the	 two	 other	 main	 clinical	 signs	 of	 IAD	 -	 decreased	 racing	 performance	
(9,59,71,72)	and	coughing	(see	previous	section	-	2.5.2)(62,63,69).	
	






with	no	evidence	of	mucus	were	 found	 to	have	an	 inflammatory	BALF	 (18).	 In	
contrast	 to	 these	 studies,	mucus	accumulation	 scores	have	also	been	 shown	 to	
correlate	well	with	TW	and	BALF	neutrophil	percentages	(65).		
	












There	 has	 been	 no	 reported	 association	 between	 blood	 inflammatory	 markers	










Based	 on	 the	 assumption	 that	 IAD	 is	 a	 diffuse	 disease,	 lung	 biopsies	 were	
evaluated	 in	 a	 study	 by	 Persson	 and	 Lindberg	 (1991)	 to	 evaluate	 exercise	
intolerance	in	athletic	horses	(3).	This	was	based	on	earlier	findings	that	biopsy	
pathology	 from	 horses	 with	 RAO	 was	 correlated	 with	 necropsy	 findings	 that	







biopsy	 is	 the	 seventh	 or	 eighth	 inter-costal	 space	 8cm	 above	 a	 horizontal	 line	
across	the	elbow	joint	(76).	
	





biopsy	 sample	 obtained	 from	 the	 caudal	 aspect	 of	 the	 caudal	 lung	 lobe	 is	





Endoscopy	 is	 an	 important	 tool	 used	 in	 the	 investigation	 of	 equine	 upper	 and	
lower	 airway	 disease.	 It	 allows	 for	 visual	 assessment	 of	 the	 trachea	










Endoscopic	 examination	 of	 the	 trachea	 also	 allows	 for	 collection	 of	 mucus	 for	
cytological	examination	–	a	procedure	known	as	a	tracheal	wash	(TW).	Tracheal	
wash	samples	are	representative	of	both	the	peripheral	and	central	airways	(76).	











The	 relationship	 between	 tracheal	 mucus	 accumulation	 and	 TW	 cytology	 is	
unclear	 with	 studies	 both	 reporting	 and	 denying	 an	 association.	 Neutrophilic	
inflammation	 may	 cause	 mucus	 accumulation	 in	 horse	 airways	 through	
increased	 production	 and	 secretion	 of	 mucins	 (81)	 or	 by	 altering	 the	 physical	
properties	and	thus	the	clearance	of	mucociliary	secretions	(82).	Durando	et	al.	




In	 support	 of	 Durando	 and	 co-worker’s	 (2006)	 findings,	 other	 studies	 have	
reported	that	only	increased	tracheal	mucus,	and	not	increased	TW	neutrophils,	
was	associated	with	poor	 racing	performance	 in	Thoroughbreds	 (71)	and	with	
reduced	willingness	to	perform	in	show-jumpers	and	dressage	horses	(83).	This	
suggests	 that	TW	cytology	may	not	 consistently	 represent	deeper	processes	 in	
the	lung	that	produce	mucus.		
	
The	 relationship	 between	 tracheal	 and	 bronchoalveolar	 fluid	 cytology	 is	 also	
unclear,	 again	 with	 studies	 both	 reporting	 and	 denying	 any	 association.	 A	
significant	 correlation	 was	 reported	 between	 the	 percentage	 of	 neutrophils	 in	
TW	 and	 BALF	 samples	 in	 horses	 with	 IAD	 (9)	 and	 in	 horses	 with	 or	 without	







An	 increase	 in	 the	 relative	 number	 of	 tracheal	 neutrophils	 could	 be	 an	
adaptation	to	increased	exercise	and	not	necessarily	a	pathogenic	response	(84).	






Bronchoalveolar	 lavage	(BAL),	colloquially	known	as	a	 ‘lung	wash’,	 is	a	method	
for	the	recovery	of	respiratory	secretions	that	line	the	distal	airways	and	alveoli.	
The	 procedure	 is	 considered	 safe,	 repeatable	 and	 has	 few	 reported	
complications	 (74).	 Good	 correlation	 between	 BAL	 fluid	 (BALF)	 cytology	 and	
histopathological	pulmonary	cellular	patterns	has	been	reported	(86).	In	general,	
tracheal	 wash	 and	 BALF	 cytology	 findings	 do	 not	 correlate	 well	 and	 the	 latter	




There	 is	 no	 standardized	 equine	 BAL	 technique,	 with	 wide	 variations	 in	 both	







The	 cell	 population	 of	 the	 equine	 lower	 airways	 is	 essentially	 uniform	 and	 a	
single	 BALF	 sample	 collected	 from	 any	 lung	 segment	 is	 considered	 to	 be	
representative	 of	 the	 entire	 lung	 (89).	 Pulmonary	 alveolar	 macrophages	 and	








to	 differences	 in	BAL	 volume	 and	 techniques	 used.	 Total	 cell	 counts	 (TCC)	 are	
deemed	of	little	diagnostic	use	due	to	the	variable	and	unknown	dilution	factor	








































































































































































2.6.5.1 BAL volume 
 
The most important technical factor that influences reported ‘normal’ valves for 
BALF differential cell count amongst various research groups is differences in 
the volume of fluid used for lavage.  This appears to be of critical importance 
when comparing studies. Depending on the technique used neutrophils 
constitute less than 10% of total number of nucleated cells (80,86). This upper 
limit of normal reduces to 5% when larger fluid volumes are used (7). Human 
BALF studies have shown that lavage volumes less than 20 mL increase the 
proportion of bronchial epithelial cells and neutrophils and decrease the 
proportion of alveolar macrophages and lymphocytes compared to larger 
volume lavages (92). Hence, the first aliquot is most representative of bronchial 
material, whereas subsequent aliquots contain more bronchoalveolar secretions 
(93). If smaller lavage volumes are used, the volume recovered is lower and the 
cell differential richer in neutrophils and contains fewer mast cells (80).  
 
Controversy also exists on the necessity to analyse one or several BAL aliquots 
for the diagnosis of lung diseases. One study refutes the need for higher volumes, 
showing that sequential aliquots of saline (100 mL each) did not significantly 
differ from a pooled sample (300 mL)(94), but mast cell percentages have been 
shown to be higher in the first aliquot (95). Pickles et al. (2002) reported that 
although variations were observed, there was no significant difference in 
nucleated or differential cell counts among sequential and pooled BALF aliquots 
in clinically normal horses and horses with RAO (95). The author does however 
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acknowledge that lack of statistical significance may be due to the small sample 
size in the study (n=21).  
 
Pooling aliquots or using different lavage volumes has been documented to 
influence the number of mast cells recovered and identified in BALF (80,96). 
Jean et al. (2011) found a significantly higher percentage of neutrophils and 
lower percentage of macrophages in first aliquot compared to second aliquot for 
horses in both control and RAO groups (97). The second aliquot diffuses farther 
into the airways to reach the alveolar spaces.  
 
The use of higher volume lavage (300-500 mL) overcomes these reported 
inconsistencies, most likely because of the greater surface area sampled (98). An 
international workshop on equine chronic airway disease recommended the use 
of between 300 and 500 ml of lavage fluid to obtain consistent results 
comparable to the published reference ranges (2). Pleural leakage of fluid has 
been shown to occur with continuous infusion of volumes in excess of 450 ml 
(86).  
 
A variety of inflammatory cell profiles may be displayed in horses with IAD (36, 
74). One or more inflammatory cell types may be elevated as follows: 
mastocytosis (mast cells >2%), eosinophilia (eosinophils >1%)(99), or mildly to 
moderately increased neutrophils (16,19,50,73,91,100). Sanchez et al. (2005) 
reported that the absolute number of lymphocytes and the relative percentage of 
lymphocytes were significantly higher in horses with IAD than other animals 
(18). It has been suggested that these different inflammatory cell profiles may 
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reflect different aetiologies or environmental exposures and immune responses 
to disease or alternatively may represent different stages of disease (36).  
 
Although some authors have reported an association between mast cells in 
excess of 2% in BALF and exercise intolerance in racehorses (64,101,102), 
others question the significance of this and report ranges of 0.7 to 12.3% for 
mast cells in BALF from horses showing no clinical evidence of respiratory tract 



















































































































2.6.5.2 BAL Catheter Location  
 
A blindly passed BAL catheter has been shown to sample the dorso-caudal area 
of the lung (86). It is assumed that a single BALF sample taken from any site is 
representative of the entire lung and the technique is therefore recommended 
for the diagnosis of diffuse rather than localised diseases of the lung (86). Lung 
disease localised to other areas of the lung would not be detected, although it 
may however result in an impairment of pulmonary function and abnormal 
clinical signs. Conversely, if the cytological changes observed in the BALF are 
abnormal and are localized to the caudal areas of the lung, function of the entire 
lung may not be measurably decreased (17,37). Some caution must therefore be 
used in assessing the functional significance of abnormal BAL findings.  
 
In a study of horses presented with poor performance, Davidson et al. (2011) 
found that 41% of horses with abnormal BAL cytology had impaired blood gas 
exchange but they could not identify a significant relationship between IAD and 
increased exercise-induced hypoxemia (37). This supports the hypothesis that 
the BAL sample may not be representative of the global lung pathology.  
 
The presence of inflammatory cells in BALF is dependent on an intraepithelial or 
intraluminal position in the small airways. In a study by Fogarty (1990), 
pulmonary eosinophils were only detected in BALF in 40% of lungs that had 
eosinophilic infiltrates on histopathology. This finding is mainly due to the 
interstitial position of the eosinophil and highlights that interstitial pulmonary 
disease will not be reflected to the same degree of accuracy as bronchoalveolar 
 30 
disease (86). Likewise, mast cell detection in BALF is dependent on an 
intraepithelial or intraluminal position of these cells in the small airways (86).   
 
Although it is assumed that cell populations are similar in BALF recovered from 
different sites of the lung, significant differences in the relative percentage of 
mast cells have been reported between the left and right lungs (80,97). There is 
no clear explanation for these reported site differences in the relative percentage 
of mast cells. 
 
2.6.5.3 Effect of prior BAL on subsequent cytology 
 
Studies have shown that the BAL procedure has no effect on subsequent BAL 
cytology (103,104) and does not result in histopathological evidence of 
inflammation (86).  Others have suggested however that the procedure may 
induce transient localised inflammation in the sampled region for at least 48 
hours, as demonstrated by an increase in neutrophils (105). There is no evidence 
that BAL causes any significant disturbance in lung function; indeed, in one study, 
the BAL procedure was associated with an improvement in airway function, 
which the group attributed to the removal of mucus (106) by the wash.  
 
2.6.5.4 Effect of exercise on BALF cytology 
 
The effect of exercise on the cytological evaluation of respiratory fluids remains 
controversial. It is customary to perform BAL after exercise rather than before, 
because mucus can be observed more readily at this time (98). It is suggested 
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that higher intensity exercise may be associated with a low-grade inflammatory 
response in the lower airway due to increased exposure to aerosolized irritants 
and other environmental factors during maximum ventilation (85). This theory 
is supported by a number of studies in which increased BALF neutrophil counts 
have been found in horses in higher intensity training (19,37,57,85). Low 
volumes of lavage fluid were used in both McKane and co-worker’s (1993) and 
Courouce-Malblanc and co-worker’s (2010) studies, which is likely to have had 
an influence on their results. Although Couetil and Denicola (1999) 
demonstrated higher neutrophil numbers in post exercise BAL samples, this 
increase was small and not significant (19). A study by Clark et al. (1995) 
concluded that exercise did not alter BAL cytology (103) suggesting that training 
does not elicit a significant inflammatory response in the lower airway.  
 
2.6.5.5 Laboratory analysis 
 
The BALF recovered is pooled and a well-mixed sample is placed into sterile 
containers containing EDTA for centrifugation (600g, 5 min). It is important to 
centrifuge the samples to produce a uniform, monolayer and adequate number 
of cells to examine microscopically (88). The European Society of Pneumonology 
Task Group on BAL recommends a cytocentrifugation speed of 800 rpm (90 g) 
for optimal lymphocyte preservation in human BALF (107).  
 
A smear slide may also be prepared. Pickles et al. (96) showed that smear 
preparations are reliable for the cytological diagnosis of equine neutrophilic 
pulmonary disease. The study found no significant difference in neutrophil 
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differential cell count between cytocentrifuged and smear preparations of BALF. 
Smear preparations did produce smaller, darker staining cells, making 
cytological identification more difficult than on cytocentrifuged preparations. 
Smears should be air-dried as quickly as possible to preserve cell quality (88).  
 
In a study to evaluate the effects of time, temperature and different fixatives on 
BALF cytology, Pickles et al. (2002) found that storage at 4oC was optimal for 
diagnostic purposes (108). The research group found that BALF can generally be 
stored at room temperature if processed within 8 h, but should be refrigerated if 
processing is to take place 8-24 h after collection, as cell viability decreases with 
increasing temperature and time. Unfixed samples showed a progressive 
deterioration in cell morphology with increasing time. Therefore, it is 
recommended that if BALF is to be processed over 24 hours after collection, a 
formalin- or alcohol-based fixative should be added (108).  
 
Cytocentrifuge or smear slides can be stained with a variety of commercial stains, 
including Romanowsky (Diff-Quik®), Wright’s-Giemsa, May-Grunwald-Giemsa, 
and Leishman’s stain. Prussian blue stain may be used for staining of 
hemosiderin if desired. The Romanowsky stain is the easiest to use in the 
practice environment but has the disadvantage that mast cell granules stain 
poorly as the stain is not metachromatic (109), making the enumeration of mast 
cells dependent on cell morphology (110). A number of studies on lower 
respiratory tract cytology in horses have only used the Romanowsky stain and in 
most of these low numbers of mast cells have been identified (85), potentially 
contributing a bias to the reported results.  
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Toluidine Blue has been shown to have the greatest sensitivity for the detection 
of mast cells (110), but this stain does not allow identification of other cell types. 
A general recommendation is to use the Romanowsky stain for differential cell 
counts and Toluidine Blue (30 minutes) for mast cell differential counts, which 
are counted separately (98).  
 
The 400-cell leukocyte differential count, using a bright-field microscope at high 
power (630 to 1000 x) magnification, is a standard cell counting method for 
equine BAL samples (98). A differential count of particular classes of 
inflammatory cells is expressed as a percentage of the total inflammatory cells 
rather than enumeration of absolute numbers per unit volume of sample (94). 
This method does not take into account cell density and uneven cell distribution 
in a cytocentrifuged preparation. A recent study evaluating the inter-rater 
reliability of 400-cell leucocyte differential counts in equine BAL compared with 
an alternative method in which 5 microscopic fields were evaluated at 500 x 
magnification found that although reliability was higher for the 5 field method, 
overall the difference between methods was not significant (111).  
 
2.6.6 Pulmonary function testing 
 
Pulmonary function testing (PFT) can aid in establishing a definitive diagnosis of 
IAD. The technique has the additional benefit of providing an objective method of 
monitoring a response to therapy. A variety of pulmonary function testing 
methods are available but few are non-invasive. The equipment is often 
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cumbersome, expensive or complicated and as a consequence use is generally 
limited to research facilities. Techniques used in horses include: 1) conventional 
lung mechanics using pleural pressure measurements; 2) forced oscillatory 
mechanics; 3) forced expiratory manoeuvres; and 4) plethysmography.  
 
2.6.6.1 Conventional lung mechanics using pleural pressure measurements 
 
The conventional lung mechanics technique is based on the oesophageal balloon 
technique described by Derksen and Robinson (112), and measures pressure 
and flow variations resulting from the horse’s spontaneous breathing. 
Oesophageal pressure is measured by means of a balloon-tipped catheter 
advanced into the distal third of the thoracic oesophagus and connected to a 
pressure transducer. The other side of the pressure transducer is connected to 
the mask via a similar catheter. Transpulmonary pressure is then calculated 
from the difference between mask pressure and oesophageal pressure (76,113). 
Variables that may be measured include maximum change in transpulmonary 
pressure, tidal volume, inspiratory time, expiratory time, peak inspiratory flow 
rate, peak expiratory flow rate, breathing frequency and minute ventilation. 
Values for pulmonary resistance and dynamic lung compliance are then 
computed (114). The conventional lung mechanics technique using pleural 
pressure measurements in horses lacks sensitivity, and often only detects 





2.6.6.2 Forced oscillation techniques (oscillometry) 
 
Forced oscillation techniques (FOT) measure the response of the respiratory 
system to external forces (115). Techniques are non-invasive, readily tolerated 
and require only a facemask on the patient. FOT impose sinusoidal oscillations 
from an external source of energy through the respiratory system to generate 
similar pressure flow responses from the respiratory system that are measured 
at the airway opening. Natural fluctuations of airway pressure and flow due to 
breathing are filtered out. The amplitude and synchrony of the flow and pressure 
oscillations from the respiratory system determine lung function by measuring 
total respiratory impedance in a specific spectrum of frequencies. Total 
impedance across the respiratory tract, is related to the behaviour of 3 
independent forces that act in series: resistance, elastance, and inertance. 
Resistance describes pressure due to friction, elastance describes pressure due 
to tissue recoil, and inertance describes pressure related to acceleration of flow. 
As one factor changes relative to the other, total impedence varies (115). The 
impulse oscillometry system (IOS) is a non-invasive respiratory function test 
based on the forced oscillation principle and has been validated in horses (116). 
The system applies multi-frequency external signals, generated with a 
loudspeaker, and the respiratory system produces a pressure flow signal 
response measured by a pneumotachograph and pressure transducers. Total 
respiratory resistance and reactance is recorded (117). The IOS was more 
sensitive than the conventional lung mechanics method, based on the 
oesophageal balloon technique, in detecting changes in respiratory impedance in 
RAO-affected horses (118). Changes in airway resistance and reactance during 
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each phase of respiration were demonstrated in a population of young 
racehorses with apparent IAD (119). 
 
2.6.6.3 Forced expiratory manoeuvres 
 
Forced expiration (FE) is one of the most useful and commonly used pulmonary 
function tests for the early detection of small airway disease in humans 
(115,120). The FE technique requires patients to inhale until they have achieved 
total lung capacity and to then exhale as hard and completely as possible while 
expiratory flow and volume are recorded. Such manoeuvres can be performed in 
animals, but require the use of general anaesthesia to avoid interference of 
conscious respiratory movements with emptying of the lungs. FE manoeuvres 
are rarely performed in horses because the methods are invasive and 
cumbersome. 
 
Couetil et al (2000) developed a minimally invasive and non-plethysmographic 
FE method for use in horses that were sedated but not anaesthetised. They 
concluded that peripheral airway obstruction was detectable through the 
analysis of the forced expiratory flow-volume (FEFV) curves (120). Horses with a 
history of inflammatory airway disease have lower values for forced expiratory 




Whole body plethysmography has been successfully used for respiratory 
measurements in human subjects since the mid-1950s. At an international 
 37 
symposium on lung function and respiratory diseases in the horse in 1985 
Beadle described his experiences with whole body plethysmography in horses 
with RAO (121). The plethysmograph described was a set of stocks welded to a 
square steel tubing chassis, which in turn was incorporated by an airtight box 
(Figure 1). The wall and ceiling of the box were made from 19 mm thick plywood 
attached to an angle iron framework and the floor was made from 6 mm thick 
steel plating. The door and window were sealed when closed by means of 
specially designed gaskets constructed from closed cell foam rubber weather-
stripping material coated with latex rubber. Two breathing circuits were built 
into the box. Circuit 1 measured thoracic gas volume and circuit 2 measured 
alveolar pressures.  
 
 
Figure 1: Box plethysmograph as described by Beadle (121) 
 
Box-less or ‘flowmetric’ plethysmography (FP) is a recently developed non-
invasive lung function testing method. In horses, FP (trade named “Open Pleth”) 
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is conducted using a combination of external sensors placed on the body surface 
(respiratory inductance plethysmographic (RIP) bands) and a measure of flow at 
the nares by a pneumotachograph (Figure 2). Gas compression from airway 
obstruction results in discordance between the two sensors. The contribution of 
thoracic and diaphragmatic movements to the breathing pattern and thus 
thoraco-abdominal asynchrony can also be analysed (115). The sensitivity of the 
FP system is similar to conventional lung mechanic testing (115) and the test is 
coupled with bronchoprovocation methods to improve sensitivity.  
 
 
Figure 2: Schematic showing the components of the flowmetric plethysmographic method (122) 
 
The respiratory ultrasonographic plethysmograph (RUP) has recently been 
validated in the horse (123). This system measures the stretching of compliant 
liquid-filled rubber tubes that are fastened around the thorax and abdomen. The 
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elastic tubes function as ultrasonic waveguides between an ultrasonic 
transmitter and receiver at the respective ends.  An advantage of the RUP device 
compared to the RIP device is its relative resistance to the influence of 
electromagnetic interference (123).  
 
2.6.6.5 Bronchoprovocation testing 
 
Bronchial hyper-reactivity to pharmacological and physical stimuli is a 
characteristic of human asthma. The sensitivity of the airways to react with a 
bronchospasm, known as airway reactivity, can be determined in horses in a 
similar way to that in humans. Horses with an exaggerated response to 
pharmacological stimuli, such as a histamine aerosol challenge, are termed 
‘hyper-reactive’ and airway hyper-reactivity (AHR) is thought to be a good 
marker for inflammation of the small airways (117).  
 
The methods for bronchoprovocation in horses are adapted from those used in 
humans. The histamine bronchoprovocation test is typically performed to detect 
nonspecific AHR. Bronchial hyper-reactivity to intravenous administration of 
histamine was first described in horses with chronic airway disease in 1948 
(124). In humans, histamine inhalation has been used as a test to provoke 
bronchoconstriction to determine the level of nonspecific airway reactivity in 
asthmatics since the mid-1940s. The test is based on Poiseuille’s law, which 
states that resistance is inversely proportional to the radius of the airway lumen 
to the fourth power (20). Therefore even a slight decrease in radius with 
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exposure to a bronchoconstrictor agent during bronchoprovocation tests 
manifests an exaggerated change in airway resistance.  
 
The histamine inhalation provocation test (HIPT) can also be carried out in 
horses and has been used as a method to identify nonspecific airway reactivity in 
horses since the mid-1980s (125). Early studies have demonstrated the use of 
HIPT in association with the conventional lung function testing method 
described above (section 2.6.6.1). After determination of baseline lung function 
values, the first test solution nebulised was the solvent for the histamine 
solutions. After the 2-minute test solution inhalation, the nebuliser adapter was 
exchanged for the flow-transducer, and lung function was tested about 60 s after 
inhalation. The following test solutions always contained histamine 
dihydrochloride with doubling concentrations. After inhalation of increasing 
concentrations of histamine solutions, horses demonstrate a decrease in 
dynamic compliance and an increase in airway resistance, work of breathing, and 
maximum intra-thoracic differences in pressure. A linear regression with the 
baseline value, the solvent value, and all values after inhalations of histamine 
solutions is carried out and the histamine concentration that resulted in a 35% 
reduction in dynamic compliance (Cdyn) is calculated. This concentration was 
called 35% provoking concentration (PC35 Cdyn). Nonspecific airway hyper-
reactivity was not present in horses that did not have clinical signs of disease but 
present in 25% of horses with low grade lung disease and in all horses with 
severe lung disease (125). These findings suggested that horses with lung 




Klein (126) classified airway reactivity of horses in 1984. Normal reactivity is 
classified as a PC35Cdyn greater than 8 mg/mL histamine dihydrochloride (Table 
3).  
 
PC35 Reactivity grade 
> 8mg histamine/mL Normal reactivity 
Between 1 and 8 mg histamine/mL Low grade hyperreactivity 
Between 0.125 and 1 mg 
histamine/mL 
Moderate hyperreactivity 
<0.125 mg histamine/mL High grade hyperreactivity 
Table 3: Classification of the reactivity grades by Klein (1984)(126) 
 
Histamine bronchoprovocation can be used in combination with all of the 
previously described pulmonary function tests to increase test sensitivity. In a 
prospective study investigating the reproducibility of airway responsiveness in 
horses using flowmetric plethysmography and histamine bronchoprovocation, 
Nolen-Walston et al showed acceptable reproducibility over time periods up to a 
year (127).  
 
2.6.7 Association between BAL and PFT 
 
Studies reporting the association between BAL cytology and PFT are limited.  
Couëtil and co-workers reported that horses with inflammatory airway disease, 
as diagnosed by medical history and clinical signs of cough and increased 
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tracheobronchial mucus, had significantly lower values for forced expiratory 
flows when compared to a group of normal horses (114). Higher relative BALF 
neutrophil percentages were found in the IAD group, but a significant difference 
was not found when compared to normal horses in their study. This was likely 
due to low sample size (114).  
 
Significant correlations between BALF mast cell percentage and AHR (64, 101) 
and the relative eosinophil percentage and AHR (99) are reported. Impulse 
oscillometry system methods without histamine bronchoprovocation or 
respiratory challenge have also reported a correlation between elevated BALF 
eosinophils and mast cells with respiratory dysfunction (119).  
 
Disjunction between BALF cytology and airway hyperreactivity has been 
reported, with some horses showing abnormal lung function in the face of 
normal BALF cytology, and vice versa (128). These studies are very limited and it 
was our primary aim of this study to further investigate and characterise the 
association between BALF cytology and pulmonary function testing with 







CHAPTER 3. MATERIALS AND METHODS 
 
 
Study design – The study consisted of two parts: 
Part 1: Reliability testing 
 
Pulmonary function testing and histamine bronchoprovocation was performed 
on horses on three separate occasions at one-week intervals. All lung function 
testing was performed in an air-conditioned, temperature-controlled 
environment.  
Part 2: Data collection 
Pulmonary function testing, histamine bronchoprovocation and a 
bronchoalveolar lavage were performed on horses as outlined below.  
 
Animals - All animal testing was performed with the approval of Murdoch 
University Animal Ethics Committee (Permit number R2405/11).   
 Part 1: In part 1 of the study, 10 adult horses from a university owned 
herd were included. Subjects consisted of 4 Thoroughbreds, 5 
Standardbreds and one Arabian of which 8 were geldings and 2 were 
mares, aged from 5 to 20 years.  
 Part 2: Thirty-eight healthy adult horses from a university owned herd 
were used for the study.  Subjects consisted of 18 Thoroughbreds, 19 
Standardbreds and one Arabian, aged from 4 to 27 years.  Of these, 14 
were geldings and 24 were mares.   
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None of the horses had a recent history or clinical signs of respiratory tract 
disease. Routine physical examination was within normal limits on all horses. 
All horses were housed in a large pasture for a minimum of 4 months before 
and throughout the study. Management remained consistent throughout the 
study. 
 
Pulmonary function testing (PFT) - Pulmonary function testing and histamine 
bronchoprovocation were performed with a commercial flowmetric 
plethysmography system (Open Pleth™ using Equine Flowmetrics™ software). 
Prior to use, the system was calibrated as per manufacturer’s instructions 
(Ambulatory Monitoring, Inc.). Each horse was restrained in metal stocks, 
sedated with detomidine (0.01 mg/kg), fitted with an equine mask, 
pneumotachograph (Figure 3), and abdominal and thoracic respiratory 
inductance plethysmography (RIP) bands (Figure 4). The thoracic RIP band was 
placed between the ninth and eleventh intercostal space and the abdominal band 
was placed immediately behind the last rib. Head position was maintained on a 
stand in a consistent horizontal position (Figure 5). Firstly, baseline pulmonary 
function measurements were recorded for 3 minutes. The computer software 
(Figure 6) calculated total airway impedance, by subtracting thoracic volume 
change from pneumotachograph flow at peak expiration (delta flow). Saline 
(0.9%) was then nebulised as a control for 2 minutes and again measurements 
were recorded for 3 minutes. A series of increasing doses of histamine 
diphosphate solution was then nebulised, starting with 4 mg/mL (4, 8, 16, 32 
mg/mL). The histamine solution was nebulised for 2 minutes and lung function 
data was collected for 3 minutes. The test was discontinued when the measured 
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response exceeded baseline delta flow by 50% or a maximum of 32 mg/mL of 








Figure 4: Thoracic and abdominal respiratory inductance plethysmography (RIP) bands were placed 








Figure 6: Computer system recording during the pulmonary function test 
 
The data was manually reviewed and abnormal breaths due to excessive 
movement removed. A dose-response curve was then generated and the 
concentration of histamine that evoked a 35% increase in delta flow above 
baseline (PC35) was computed by interpolation of the dose-response curve. 
Airway hyper-reactivity was expressed as a PC35 value. Airway hyper-reactivity 
was categorised into normal (PC35: ≥ 8 mg/mL), mild (PC35: 4-8 mg/mL), 
moderate (PC35: 2-4 mg/mL) or severe (PC35: < 2 mg/mL).  
 
PC35 (mg/mL histamine) Final airway reactivity category 
 8 Normal 
4-8 Mild 
2-4 Moderate 
< 2 Severe 
Table 4: Categories of airway reactivity 
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Horses were also categorised as being ‘normal’ if PC35 was greater than 8 mg/mL 
histamine or ‘reactive’ if PC35 was less than or equal to 8 mg/mL histamine. 
PC35 (mg/mL histamine) General airway reactivity category 
 8 Normal 
  8 ‘Reactive’ 
Table 5: General categories of airway reactivity 
 
In part 1 of the study a subjective assessment of when the horse 
bronchoprovocated was also recorded. This involved documenting the 
concentration of histamine being nebulised when respiratory rate and depth 
increased ‘significantly’ above normal. 
 
Bronchoalveolar lavage (BAL) – In part 2 of the study, a BAL was performed in 
all horses between 1 and 5 days post PFT.  The majority of horses were tested at 
24 hours post PFT. Horses were sedated with detomidine (0.01 mg/kg) and 
butorphanol tartrate (10-30 µg/kg) and were restrained in stocks with a twitch 
applied to the upper lip.  BAL was performed using the blind technique (86, 88). 
A commercial cuffed BAL tube (Bivona ®) (Figure 7) with a diameter of 11 mm 
and a length of 244 cm was passed blindly through the ventral nasal meatus into 
the pharynx (Figure 8). The head was stretched into a horizontal position and 
the tube is advanced into the trachea, whereby a complete lack of resistance and 
manual rattling of the tube in the trachea confirmed its correct positioning. As 
the tube was passed down the trachea, 0.2% lidocaine (40 mL) was infused 
slowly through the tube (129) to desensitize the bronchial mucosa and reduce 
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coughing. The BAL tube was gently advanced until it could not be advanced 
further, the cuff on the BAL tube was then inflated with air (7-10 mL) and the 
tube gently pressed against the nasal septum with the thumb to secure its 
position. A total of 300 mL sterile isotonic saline at room temperature, divided 
into two aliquots of firstly 180 mL and then 120 mL, was infused into the 
alveolar space using 60 mL syringes (Figure 9). After each aliquot was infused it 
was gently aspirated (Figure 10) and once no further fluid was recovered on 
aspiration of the final infusion the cuff was deflated and the BAL tube removed. 
The 2 samples were subsequently pooled in a sterile container (Figure 9). BAL 
samples were considered adequate if they contained frothy material denoting 
the presence of surfactant (50) and there was greater than 50% of the volume 
retrieved. Samples were immediately placed on ice and transported within 30 






Figure 7: Bronchoalveolar lavage tube primed with 0.2% lidocaine with cuff inflator syringe 




Figure 8: The horse is sedated and restrained in stocks with a nose twitch applied. The BAL tube is 




Figure 9: Bronchoalveolar lavage tube is gently pressed against the nasal septum with the thumb to 
secure its position at the nostril while saline is infused using 60 mL syringes 
 
Figure 10: After each aliquot of saline is infused it is then gently aspirated using 60 mL syringes 
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Figure 11: Sterile pot containing the two-pooled BAL aliquots. The frothy material on top denotes 
the presence of surfactant. 
 
Sample handling - All samples were processed within 30 minutes of collection. 
Twenty millilitres of BALF was centrifuged at 2500 g for 10 minutes, the 
supernatant was collected and frozen to -80 degree Celsius (this was used in 
another study). Another sample of BALF was stained with methylene blue dye 
and total nucleated cells were counted manually using a Neubauer 
haemocytometer.  Slides were prepared by cytocentrifugation of the remaining 
pooled sample and stained with Leishman’s stain.  Differential cytological counts 
of all samples were performed by the same person, an experienced clinical 
pathologist, by counting a minimum of 400 cells using high power (630 x) light 
microscopy. Cells were classified as the percentage of macrophages, lymphocytes, 
neutrophils, mast cells and eosinophils. 
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Data analysis - In part 1, reliability was investigated using an intra-class 
correlation coefficient (Type C) for both objective and subjective data. 
 
In part 2, data were organised into separate datasets based on inflammatory cell 
responses observed and categorized as follows:  
0) Normal 
1) Mastocytosis only: mast cells > 2% 
2) Eosinophilic response only: eosinophils ≥ 1% 
3) Neutrophilic response only: neutrophils >5% 
4) Mixed type 1 response: neutrophils >5% plus mast cells >2% 
5) Mixed type 2 response: mast cells > 2% plus eosinophils ≥1% 
6) Mixed type 3 response: neutrophils >5% plus eosinophils ≥1% 
7) Mixed type 4 response: neutrophils >5% plus mast cells > 2% plus 
eosinophils ≥1% 
 
The data were not normally distributed on the basis of a significant Shapiro-Wilk 
statistic.  Consequently a Spearman’s correlation was used to assess age, total 
nucleated cell count and inflammatory cell responses observed and airway 
hyperreactivity (PC35).  Chi-squared analysis was used to compare all categories 
of inflammatory cell response (0-7) observed with the final category of airway 
reactivity (normal, mild, moderate or severe) and the general category of airway 
reactivity (‘normal’ or ‘reactive’) in every horse. Comparisons between 
categories using the independent variables relative cell percentage and PC35 
values were undertaken using a Mann-Whitney U test.  Significance was defined 
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as P < 0.05. All statistical analyses were performed by use of commercial 



















In part one of the study, 30 pulmonary function tests (PFT) with histamine 
bronchoprovocation were performed. On manual review of the PFT data, all 3 
tests for horse number 10 and one test for horses’ number one and 6 were 
deemed to be inaccurate, and these test results were excluded from data analysis. 
Two horses developed nasal oedema during pulmonary function testing on 2 
individual occasions, precluding use of data in these instances. Objective data 
was collected in 23 instances and indices of airway reactivity (PC35 values) are 
listed in Table 6 below. Subjective data was collected in all thirty horses (Table 
7).  
 
Table 6: Objective data for part 1 of study showing PC35 values 
Horse No. 
PC35 (mg histamine/mL) 
Week 1 Week 2 Week 3 
1 * 10.77 4.69 
2 2.14 5.51 5.44 
3 9.27 8.25 NO 
4 11.01 9.08 10.84 
5 6.29 5.01 5.15 
6 3.26 * 5.34 
7 3.53 7.23 5.24 
8 6.28 4.13 5.24 
9 NO 12.64 5.44 
 56 
Horse No. 
PC35 (mg histamine/mL) 
Week 1 Week 2 Week 3 
10 * * * 
*Result removed as deemed inaccurate after manual review; NO: Nasal oedema 
A Type C intra-class correlation coefficient (ICC) was calculated for single 
measures for both objective and subjective data. The ICC for objective data was 
0.655 (95% CI: 0.098, 0.952; significance: 0.011) and for subjective data was 
0.932 (95% CI: 0.773, 0.987; significance: < 0.001).  
Table 7: Subjective data for part 1 of study showing histamine 
concentration at which horses subjectively bronchoprovocated 
Horse No. 
Histamine concentration (mg/mL) 
Week 1 Week 2 Week 3 
1 8 8 8 
2 8 8 8 
3 16 16 NO 
4 16 16 16 
5 8 8 8 
6 4 8 8 
7 4 8 8 
8 8 8 # 
9 NO 16 8 
10 16 16 16 




In part two of the study, 5 horses had incomplete data for airway reactivity due 
to failure of the pulmonary function-testing unit and were thus omitted from 
data analyses. All horses were clinically normal on routine physical examination. 
A BAL was performed on all horses. No adverse effects of the lavage procedure 
were documented. Cell differential percentages, category of inflammatory cell 
response, PC35 values and airway reactivity category are listed in Table 8 below 
(see Appendix 1 for table of raw numbers).  Cell percentages have been rounded 
to average numbers and thus total percentages of cells do not always equate to 
100%. 
 
Table 8: BAL cell differential percentages and PC35 values  
Horse 
No. 










Mac Lymph Neut Mast Eos 
1 52 38 5 4 0 1 1.63 Severe 
2 48 38 12 1 0 3 2.26 Moderate 
3 67 22 2.5 3 4 5 2.14 Moderate 
4 31 32 5 1 30 2 4.69 Mild 
5 70 20 8 0.5 0.5 3 4.83 Mild 
6 50 31 14 4 1 7 NR NR 
7 46 45 7 1.5 0 3 5.34 Mild 
8 72 12 10 2 2 6 5.15 Mild 














Mac Lymph Neut Mast Eos 
10 59 25 7 5 3 7 5.44 Mild 
11 52 28 5 2.5 22 5 5.44 Mild 
12 47 41 10 1.5 0 3 6.84 Mild 
13 74 15 4 3 5 5 8.25 Normal 
14 52 36 8 3 1 7 10.59 Normal 
15 51 33 13 1.5 1 6 9.33 Normal 
16 74 15 6 3 1 7 11.8 Normal 
17 56 22 8 3 10 7 12.94 Normal 
18 41 49 6 3 1 7 15.25 Normal 
19 63 26 5 3 2 5 16.00 Normal 
20 59 32 5 3 0 1 15.90 Normal 
21 46 38 10 6 0 4 4.69 Mild 
22 48 39 9 5 3 7 9.19 Normal 
23 35 55 3 4 3 5 0.84 Severe 
24 43 45 7 2 1 6 NR NR 
25 60 23 4 5 6 5 NR NR 
26 66 27 5 1 0 0 7.07 Mild 
27 39 55 4 1 0 0 13.95 Normal 
28 66 22 4 6 0 1 15.44 Normal 














Mac Lymph Neut Mast Eos 
30 63 22 10 2 2 6 18.60 Normal 
31 76 10 9 5 0 4 5.14 Mild 
32 39 40 13 7 0 4 31.93 Normal 
33 39 38 20 3 0 4 3.30 Moderate 
34 30 38 28 2 0 3 12.08 Normal 
35 36 15 20 4 24 7 NR NR 
36 38 42 12 6 1 7 NR NR 
37 20 35 39 0 2 6 9.00 Normal 
38 40 36 17 3 3 7 1.18 Severe 
Mac: macrophages; lymph: lymphocytes; neut: neutrophils; mast: mast cells; and 
eos: eosinophils; abnormal cell percentages are highlighted in red; NR: not 
recorded 
 
Bronchoalveolar lavage cytology results 
 
Ninety-five per cent (36/38) of horses were diagnosed with inflammatory 
airway disease in respect to BAL cytological findings as per definition of the 
disease by the Havemeyer Foundation Workshop in 2002 (36), with the 
exception that eosinophil percentages greater than or equal to 1% were used in 
this study. Twenty-three horses (61%) were found to have a pulmonary 
eosinophilia and 3 horses had eosinophil percentages exceeding 20%. 
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Pulmonary function test results 
 
Airway hyperreactivity (PC35 < 8 mg/mL) was demonstrated in 52% (17/33) of 
horses examined. Three horses were severely hyperreactive (PC35 < 2 mg/mL), 3 
were moderately reactive (PC35 2-4 mg/mL) and 11 were mildly reactive (PC35 4-
8 mg/mL).  
Categories of inflammatory cell response 
 
Table 9 below outlines the number of horses per category of inflammatory cell 
response. Twenty-seven horses (71%) were found to have a mixed inflammatory 
cell response, 5 (13%) had a sole neutrophilic response, 3 had a sole 
mastocytosis and one horse a sole eosinophilic response.  
 








Number of horses 
in category 




0 Normal 2 10.51 ± 4.85 
1 
Mast cells only > 
2% 








Number of horses 
in category 




2 Eos only ≥ 1% 1 4.69  
3 Neuts only > 5% 5 6.27 ± 3.64 
4 
Mixed type1 
Neuts > 5% plus 
mast > 2% 
5 13.47 ± 12.93 
5 
Mixed type 2 
Mast > 2% plus 
eos ≥ 1% 
6 6.53 ± 6.03 
6 
Mixed type 3 
Neuts > 5% plus 
eos ≥ 1% 
5 10.52 ± 5.71 
7 
Mixed type 4 
Neuts > 5% plus 
mast > 2% plus 
eos ≥ 1% 
11 8.82 ± 4.82 
Mac: macrophages; lymph: lymphocytes; neuts: neutrophils; mast: mast cells; and 




No correlation was found between age, total cell count or inflammatory cell 
responses and indices of airway reactivity. No correlation was found between 
category of inflammatory cell response observed and general or final category of 
airway reactivity.  
 
Table 10 below outlines the mean neutrophil, mast cell and eosinophil 
percentages and general category of airway reactivity. 
 






















< 8 ‘Reactive’ 17 8.7 ± 4.7 2.8 ± 1.7 4.6 ± 8.6 
≥ 8 ‘Normal’ 16 11.1 ± 9.7 3.0 ± 1.8 1.8 ± 2.6 
 
No statistical association was found between independent relative inflammatory 
cell percentages and general or final category of airway reactivity. 
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CHAPTER 5. DISCUSSION 
 
In this study we found no association between BALF cytology and airway 
hyperreactivity (PC35 value  8 mg/mL) using flowmetric plethysmography.  
 
Bronchoalveolar lavage cytology findings 
 
Ninety-five per cent of horses in this study were diagnosed with IAD based on 
international inclusion criteria outlined by the Havemeyer Foundation 
Workshop in 2002 (36). This was an unexpected finding. Other studies have 
reported that IAD is very common in horses in conventional stable environments 
(55) and an acute increase in airway neutrophils has been reported in response 
to stabling (27, 30), potentially due to the increase respiratory load of inhaled 
irritants. The horses in this study were housed outdoors and we thus 
hypothesise that these inflammatory changes are potentially due to 
environmental allergens.  
 
Overall the majority of horses (71%) demonstrated a ‘mixed’ type inflammatory 
response, the most common of which involved a combination of neutrophil, mast 
cell and eosinophil increases. Sole increases in individual inflammatory cells 
alone were less common which resulted in small sample sizes when horses were 
categorized. There was only one horse with a sole eosinophilic response and 
only 2 horses were classified as ‘normal’ in regard to BAL cytology. These small 
sample sizes in some groups are a source of Type II error in the study and thus 
the interpretation of statistics should be taken with caution. 
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Sixty-one per cent (23/38) of horses examined had a pulmonary eosinophilia 
(eosinophils ≥ 1%), which was also an unexpected finding in our study. 
Pulmonary eosinophilia has been described in horses with IAD (61, 99) but the 
significance of this finding remains unclear. In humans with allergic asthma the 
eosinophil is the hallmark respiratory inflammatory cell (130, 131). Transient 
pulmonary eosinophilia is reported in horses (132-134). Potential causes of 
eosinophilic pulmonary inflammation in horses include migrating parasites 
(Parascaris equorum)(134) or lungworm infection (Dictyocaulus arnfeldi)(135), 
idiopathic chronic eosinophilic pneumonia (136) or multisystemic eosinophilic 
epitheliotropic disease (135). The latter two mentioned conditions are 
characterised by progressive onset of respiratory clinical signs with pulmonary 
eosinophilia (135, 136) and can thus be excluded as potential differentials in the 
horses in our study. In Riihimaki’s study (133), transient pulmonary eosinophilia 
was also an unexpected finding and abated with deworming treatment (137). 
The possibility that migrating parasites could be a precipitating cause of 
pulmonary eosinophilia in some of the horses in our study cannot be definitively 
ruled out. Although faecal parasite testing was not performed, the mature age of 
the horses makes pulmonary ascariasis unlikely (138). A deworming programme 
was in place but on further epidemiological investigation the horses were 
reported to have a history of having grazed land previously inhabited by 
donkeys and the effectiveness of the anthelmintic programme is not known. 
Horses with non-patent Dictyocaulus arnfieldi infection however are reported to 
also exhibit a moist non-productive cough (138), in contrast to the horses in our 
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study which did not demonstrate any clinical signs of respiratory tract disease, 
thus making lungworm infection less likely. 
 
Our findings would incite some scrutiny in regard to BAL cytological analysis in a 
population of horses without overt clinical signs of respiratory tract disease such 
as coughing. The study highlights that what are considered normal values for cell 
proportions in BALF might vary between different populations of horses. 
Although the cell population of the equine lower airways is considered uniform 
and a single BALF sample collected from any lung segment is considered to be 
representative of the entire lung (89), BAL cytology provides no information on 
the activity of the observed cells present. There is limited data in human studies 
but these are in agreement that increased inflammatory cells in the airways are 
not associated with evidence of cell activation (84). BAL cytology may simply be 
too crude a measure of airway inflammation.   
 
Pulmonary function testing with histamine bronchoprovocation 
 
Part one of our study investigated the consistency of the Flowmetrics 
Plethysmography™ system with histamine bronchoprovocation at weekly 
intervals. Two previous reliability studies using Flowmetrics Plethysmography™ 
system with histamine bronchoprovocation have been reported in the horse 
(127, 139). In accordance with these studies sufficient consistency of 
measurements was demonstrated using the Flowmetrics Plethysmography™ 
system with histamine bronchoprovocation in our study.  An intraclass 
correlation coefficient (ICC) was used to assess reliability in our study (140). 
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Nolen-Walston and co-workers (127) used a similar method (Lin’s concordance 
correlation coefficient)(141) to assess reliability in their study. Unfortunately 
Kuehn et al. (2000) (139) did not report how their reliability statistics were 
calculated or the type of ICC used in their study. This is considered a 
fundamental error in reporting statistics (142, 143).  
 
In contrast to these prior reliability studies, we repeated testing at a shorter time 
interval. Although tachyphylaxis to inhaled histamine has been demonstrated in 
humans (144) and dogs (145), by extrapolating from these studies we believe it 
is an unlikely confounding factor in our study. In humans, it is recommended that 
repeated histamine tests should be separated by more than six hours to avoid 
tachyphylaxis (144). Testing was performed in our study at weekly intervals.  
 
Interestingly, in our study a higher ICC was calculated for subjective rather than 
objective data (0.932 v 0.655). Our reasoning for recording subjective data was 
that we hypothesised that we could determine when a horse had 
bronchoprovocated based on their clinical findings of increased respiratory rate 
and depth. A recent study (146) has named the dose of histamine at which 
inhalation was stopped as the ‘histamine challenge score’. The ‘histamine 
challenge score’ was found to produce the highest proportion of correctly 
classified RAO horses based on clinical signs of coughing and nasal discharge in 
that study.  
 
Airway hyperreactivity (PC35  8 mg/mL) was demonstrated in 52% of horses 
examined in part 2 of our study. Five horses had incomplete data for airway 
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reactivity due to failure of the pulmonary function testing unit or nasal oedema 
and were thus omitted from data analysis in part 2 of the study. Nasal oedema 
also developed in two individual horses on 2 individual occasions in part one of 
our study, precluding the use of data in these instances. The development of 
nasal oedema during pulmonary function testing has been reported in other 
studies (147-149). Nasal oedema can be caused by venous congestion that 
occurs when horses hold their head down after sedation (150-154). The severity 
of nasal oedema is correlated with the duration and degree of lowering of the 
head (151). In order to avoid the development of nasal oedema as a complication 
of sedation, the horse’s heads were placed on a stand and kept upright during 
pulmonary function testing. Local absorption of histamine can also cause 
vasodilation and increased permeability of the microvasculature (149, 155). This 
could possibly have been the cause of nasal oedema in our horses.  
 
Despite evidence that sedation alters lung function in the horse (152, 153, 156-
158), pulmonary function testing and histamine bronchoprovocation was 
unfeasible without the use of sedation in this study. It has been reported in 
previous studies that alpha-2 agonists do not block the effects of 
bronchoconstrictive agonists (histamine) and so are appropriate for restraint 
during bronchoprovocation (101, 117). The recommended approach to use the 
minimal dose of sedation possible (115, 159) was followed in our study. 
Detomidine was chosen as a sedative as it has a longer duration of activity than 




Repeated PFT’s were performed at the same time of day in part one of the study 
to avoid the potential influence of daily variations in lung parameters due to 
fluctuations in inflammatory mediations, endogenous steroids, autonomic, and 
non-adrenergic non-cholinergeic mechanisms (115, 161). Previous studies have 
shown that pulmonary function of horses with recurrent airway obstruction 
(RAO) measured with conventional methods shows daily and/or seasonal 
variation (161-163).  As the horses were housed outdoors, week to week 
variation in exposure to airway allergens was possible. 
 
Part one of the study was also performed in a temperature controlled air-
conditioned room to avoid any potential influence of air humidity or differences 
in environmental temperature on the testing system or lung function during 
reliability testing. A study by Onmaz et al (2013) found that neither outdoor nor 
indoor temperature nor room humidity had a significant effect on airway 
dynamics (163). Part two of our study was performed in non-temperature 
controlled room.  
 
Bronchoalveolar lavage cytology and pulmonary function testing findings 
 
Ninety-five percent of horses were diagnosed with inflammatory airway disease 
based on bronchoalveolar lavage cytology criteria and 52% of horses 
demonstrated airway hyperreactivity. Despite an obvious overlap in these 
findings no statistical association between bronchoalveolar lavage cytology and 
airway reactivity was found.   
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This phenomenon whereby signs of airway inflammation did not correlate with 
bronchial hyperresponsiveness has been reported in horses (128, 146, 164) and 
humans (84, 131, 165, 166). Increased numbers of inflammatory cells in the 
airways of human athletes are not necessarily associated with any major clinical 
or functional alterations (84, 165). Furthermore, humans with clinical signs of 
asthma have also demonstrated negative responses to inhaled histamine (167). 
The reasons for the finding of normal bronchial responsiveness in humans with 
current asthma symptoms have not been fully elucidated (168). It appears that 
airway hyperresponsiveness measured in response to pharmacologic agents 
such as histamine is different to that measured in response to physical stimuli, 
such as exercise and osmotic agents (167).  
 
 The converse to this phenomenon has also been demonstrated in humans in that 
a positive airway response to histamine does not infer the presence of 
inflammatory cells (131, 167, 169). The same finding has been reported in 
clinically normal horses that have been shown to demonstrate airway 
hyperresponsiveness, with normal bronchoalveolar lavage cytology (128, 146) 
or the absence of significant small airway lesions on lung biopsy (148).  
 
Airway responsiveness has been reported to be a transient finding and can 
change over time with factors such as allergen exposure and viral respiratory 
tract infections (168-170). This variability of airway responsiveness over time 
appears to be a major factor in the inconsistency of the relationship between 
airway hyperresponsiveness and clinical asthma in humans and the same theory 
is likely applicable to the horse.  
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Another suggested explanation for this inconsistency is that there may be a 
variation in the type of inflammation that causes airway hyperresponsiveness in 
the horse (128). Previous studies in horses have reported an association 
between a sole increase in mast cell percentage in BALF and airway 
hyperreactivity (101) or BALF eosinophilia and airway hyperreactivity (99). In 
contrast to these studies, no association was found between BALF mastocytosis 
or eosinophilia alone and airway hyperreactivity in our study. Likewise in 
human studies, the presence of particular inflammatory cell types is not a 
prerequisite for airway hyperreactivity (166). 
 
In agreement with Pacheco and co-workers (164), no correlation was found 
between age, BALF cytology and airway reactivity in our population of 
asymptomatic horses. Further investigation however is warranted in a 
population of horses with clinical signs of respiratory disease consistent with 




This study has achieved the primary aim of investigating the association 
between BALF cytology and PFT with histamine bronchoprovocation in a 
population of asymptomatic sedentary horses. The secondary aim to assess the 
reliability of the Open Pleth™ system using sedentary horses in Western 
Australia was also achieved. 
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The first hypothesis that there would be a strong association between lower 
airway inflammation, as demonstrated by BALF cytology, and airway 
hyperresponsiveness was not fulfilled. Despite an obvious overlap between 
BALF cytology and airway reactivity, no statistical association was found.  
Identification of horses with a cytological diagnosis of IAD without AHR was 
more common than previously reported. 
 
The second hypothesis that flowmetric plethysmography with histamine 
bronchoprovocation using the Open Pleth™ system is a reliable technique to 
detect airway hyperresponsiveness was fulfilled. Sufficient reliability was 
demonstrated.  Although the PFT technique appears to be reliable it is possible 
that both techniques may have limitations with respect to definitive 
identification of disease.   
 
A limitation to this study was the unexpected high prevalence of IAD, as 
diagnosed through both BALF cytology and PFT, in a population of outwardly 
normal sedentary horses. It is possible that unusual environmental triggers may 
have been present within this population, particularly as it relates to the high 
incidence of eosinophilia within the group. Investigations in other populations, 
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